|
End-of-day quote
LUXEMBOURG S.E.
01/10/2026
|
5-day change | 1st Jan Change | ||
| 38.00 USD | -2.56% |
|
-3.06% | +25.83% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | ||
| 1,328.83 | +15.57% | 29 | ||||||
| 279.27 | +7.97% | 22 | ||||||
| 278.86 | +7.28% | 28 | ||||||
| 155.76 | +8.31% | 25 | ||||||
| 375.34 | +7.55% | 19 | ||||||
| 151.76 | +6.77% | 22 | ||||||
| 210.47 | +32.41% | 23 | ||||||
| 390.94 | -4.01% | 29 | ||||||
| 158.65 | +7.56% | 26 | ||||||
| 307.56 | +23.02% | 23 | ||||||
| 28.91 | +2.82% | 26 | ||||||
| 571.39 | +12.76% | 28 | ||||||
| 66.71 | +8.54% | 24 | ||||||
| 979.36 | +8.96% | 14 | ||||||
| 94.06 | +28.67% | 24 | ||||||
| 21.75 | +21.16% | 21 | ||||||
| 120.67 | -36.13% | 18 | ||||||
| 853.19 | +16.11% | 26 | ||||||
| 154.21 | +14.7% | 14 | ||||||
| Average | 343.56 | +10.00% | 23 | ||||||
| Weighted average by Cap. | 496.04 | +10.86% | 25 |
- Stock Market
- Stocks
- RICHTER Stock
- CHWGR Stock
- Sector Gedeon Richter
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
